Recent news on

MAP Pharmaceuticals to Present at the CIBC World Markets Annual ...  -  Apr 10, 2007
PR Newswire (press release),...for the potential treatment of children with asthma, and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine.

Migraines? Ask Your Doctor About TPM  -  Mar 30, 2007
GNIF Brain Blogger,...acetaminophen, nonsteroidal anti-inflammatory drugs, opiates, combination analgesics, and migraine-specific treatments (ergotamine, dihydroergotamine,

MAP Pharmaceuticals Reports Positive Phase 2 Results for its ...  -  Apr 3, 2007
Drug Newswire (press release),The candidate is a proprietary orally inhaled formulation of dihydroergotamine (DHE) for the treatment of acute migraine.

MAP Pharmaceuticals Closes $50 Million Financing  -  Mar 27, 2007
PR Newswire (press release),Tempo(TM) Migraine: Tempo Migraine is an inhaled formulation of dihydroergotamine (DHE) in the Company's proprietary Tempo(TM) Inhaler platform,

Abbott Agrees With World Health Organization (WHO) Director ...  -  Apr 11, 2007
Drug Newswire (press release),...ergotamine, dihydroergotamine, ergonovine and methylergonovine), products containing St. John's wort (Hypericum perforatum) and vardenafil.

Some facts about migraines  -  Feb 7, 2007
Pittsburgh Post Gazette,Prescription anti-inflammatory agents may be effective. Migraine-specific therapies include:. Dihydroergotamine (DHE) may be used for self-injection.

African-American Women Who Have Received HIV Treatment Are Sought ...  -  Feb 7, 2007
Medical News Today (press release),...terfenadine, dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, midazolam, or triazolam) and for which elevated plasma

Heart-Valve Disease Linked to Two Parkinson's Drugs  -  Jan 4, 2007
MedPage Today,Such an association has now been seen with drugs for diverse indications, including anorectic agents (fenfluramine), antimigraine drugs (dihydroergotamine,

Study of Dasatinib or 800 Mg of Imatinib Mesylate Shows Patients ...  -  Dec 14, 2006
DG News...fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids [ergotamine, dihydroergotamine]) should be administered with caution.

A Comparison of Discharge and Two-Week Duplex Ultrasound Screening ...  Nov 1, 2006
Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. J Bone Joint Surg Br.1985; 67:538 -42. ... -Journal of Bone and Joint Surgery (subscription) Abbott's New Tablet Formulation of Kaletra'R', Lopinavir/Ritonavir ...  Sep 12, 2006
Kaletra should not be taken with astemizole, cisapride, dihydroergotamine, ergonovine, ergotamine, methylergonovine, midazolam, pimozide, terfenadine or ... -CCNMatthews

MAP Pharmaceuticals Initiates Phase 2 Clinical Trial In Patients ...  Sep 6, 2006
MAP0004 is a novel inhaled drug formulation of dihydroergotamine mesylate (DHE) administered with MAP's patented Tempo(TM) Inhaler. ... -Medical News Today

- Study of Chronic-Phase Patients with Chronic Myelogenous ...  -  Dec 11, 2006
PR Newswire (press release),...fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids [ergotamine, dihydroergotamine]) should be administered with caution.

Analysis Provides Additional Data For PREZISTA™ (Darunavir) As ...  Aug 20, 2006
PREZISTA/rtv is contraindicated with astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, midazolam and ... -Medical News Today

Abbott Statement Regarding New Initiatives To Expand Access And ...  Aug 20, 2006
...with amiodarone, astemizole, cisapride, midazolam, pimozide, terfenadine, triazolam and ergot alkaloids (eg, ergotamine, dihydroergotamine, ergonovine and ... -Medical News Today

MAP Pharmaceuticals Appoints New Program Directors  Jul 19, 2006
Borland is responsible for all development activities related to one of MAP's lead products, a novel inhaled drug formulation of dihydroergotamine mesylate (DHE ... -Yahoo! News

Abdominal Migraine and Treatment With Intravenous Valproic Acid  Jul 14, 2006
Imitrex® and IV dihydroergotamine resulted in mild but temporary relief of her abdominal pain, supporting the hypothesis that her pain episodes were due to ... -Psychosomatics (subscription)

HIV - New Tablet Formulation Of Kaletra® (lopinavir/ritonavir) ...  Jul 9, 2006
Kaletra should not be taken with amiodarone, astemizole, cisapride, dihydroergotamine, ergonovine, ergotamine, methylergonovine, midazolam, pimozide ... -Medical News Today

New Combination Of Drugs To Treat Resistant HIV Infections ...  Jun 24, 2006
The Prezista and ritonavir combination has to be taken after food and should not be used astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine ... -Food Consumer

FDA Approves Sprycel (Dasatinib) With Two Indications  Jun 29, 2006
...terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids [ergotamine, dihydroergotamine]) should be ... -DG News

PREZISTA Receives US FDA Approval as Part of HIV Combination ...  Jun 23, 2006
PREZISTA/rtv is contraindicated with astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, midazolam, and ... -Yahoo! News



APS: For Migraine and Cluster Headaches, Most Anything Is Worth a ...  May 15, 2006
...another study at his Dallas clinic, Dr. Krusz treated patients who suffered from early-morning migraine or menstrual migraine with dihydroergotamine nasal spray ... - MedPage Today





Abbott Files for Registration of Innovative Formulation for the ...  Apr 3, 2006
Lopinavir/ritonavir should not be taken with astemizole, cisapride, dihydroergotamine, ergonovine, ergotamine, methylergonovine, midazolam, pimozide ... - Finanzen.net

Intravenous Lidocaine Has Role in Refractory Chronic Headache ...  Apr 6, 2006
The trial included only patients who had failed other standard inpatient treatments such as IV dihydroergotamine, anti-emetics, and anti-inflammatories. ... - DG News

ABBOTT STATEMENT ON ADVANCING PEDIATRIC HIV TREATMENT IN ...  Mar 13, 2006
Lopinavir/ritonavir should not be taken with dihydroergotamine, ergonovine, ergotamine, and methylergonovine such as Cafergot(R), Migranal(R), DHE 45(R ... - ITNews

Abbott Statement on Advancing Pediatric HIV Treatment in ...  Mar 13, 2006
Lopinavir/ritonavir should not be taken with dihydroergotamine, ergonovine, ergotamine, and methylergonovine such as Cafergot®, Migranal®, DHE 45 ... - Yahoo! News

Boehringer Ingelheim Announces 48-week Results from Aptivus(R) ...  Feb 9, 2006
APTIVUS/r must not be taken with amiodarone, bepridil, flecainide, propafenone, quinidine, astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine ... - PR Newswire,

Boehringer Ingelheim Announces 48-week Results from Aptivus(R) ...  09 Feb 2006
APTIVUS/r must not be taken with amiodarone, bepridil, flecainide, propafenone, quinidine, astemizole, terfenadine, dihydroergotamine, ergonovine, ergotamine ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional